Clinical trials
Withdrawn Anemia, Refractory, with Excess of Blasts trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 2 |
| M.D. Anderson Cancer Center | 1 |
| Mesoblast International Sàrl | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 4 |
| Leukemia, Myeloid, Acute | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Myeloproliferative Disorders | 2 |
| Anemia, Refractory | 1 |
| Burkitt Lymphoma | 1 |
| Congenital Abnormalities | 1 |
| Graft vs Host Disease | 1 |
| Hematologic Neoplasms | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.